Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS Study)

American Journal of Cardiology

Volumn 106, Issue 11, 2010, Pages 1634-1639

  Gerdts, Eva ^a,b   Rossebø, Anne Bjørhovde ^c   Pedersen, Terje Rolf ^d,e   Boman, Kurt ^f,g   Brudi, Philippe ^h   Chambers, John Boyd ⁱ   Egstrup, Kenneth ^j   Gohlke Bärwolf, Christa ^k   Holme, Ingar ^d   Kesäniemi, Y Antero ^l   Malbecq, William ^m   Nienaber, Christoph ⁿ   Ray, Simon ^o   Skjærpe, Terje ^p   Wachtell, Kristian ^q   Willenheimer, Ronnie ^r  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c AKER UNIVERSITY HOSPITAL   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f Skelleftea Hospital   (Sweden)

^g UMEÅ UNIVERSITY   (Sweden)

^h Merck/Schering Plough   (United States)

ⁱ GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^j SVENDBORG HOSPITAL   (Denmark)

^k UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^l UNIVERSITY OF OULU   (Finland)

^m MSD Europe Inc   (Belgium)

ⁿ Abteilung für Kardiologie   (Germany)

^o MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^p TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^q Rigshospitalet   (Denmark)

^r LUND UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; SIMVASTATIN;

AGED; AORTA VALVE STENOSIS; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; AZETIDINES; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOLIPIDEMIC AGENTS; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SIMVASTATIN; TREATMENT OUTCOME;

EID: 78149452615     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.07.042     Document Type: Article

References (22)

1. B.F. Stewart, D. Siscovick, B.K. Lind, J.M. Gardin, J.S. Gottdiener, V.E. Smith, D.W. Kitzman, and C.M. Otto Clinical factors associated with calcific aortic valve disease Cardiovascular Health Study J Am Coll Cardiol 29 1997 630 634
2. N.M. Rajamannan, M. Subramaniam, M. Springett, T.C. Sebo, M. Niekrasz, J.P. McConnell, R.J. Singh, N.J. Stone, R.O. Bonow, and T.C. Spelsberg Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve Circulation 105 2002 2660 2665
3. N.M. Rajamannan, M. Subramaniam, D. Rickard, S.R. Stock, J. Donovan, M. Springett, T. Orszulak, D.A. Fullerton, A.J. Tajik, R.O. Bonow, and T. Spelsberg Human aortic valve calcification is associated with an osteoblast phenotype 13 Circulation 107 2003 2181 2184
4. V. Garg, A.N. Muth, J.F. Ransom, M.K. Schluterman, R. Barnes, I.N. King, P.D. Grossfeld, and D. Srivastava Mutations in NOTCH1 cause aortic valve disease Nature 437 2005 270 274
5. Y. Bosse, P. Mathieu, and P. Pibarot Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis J Am Coll Cardiol 51 2008 1327 1336
6. G.M. Novaro, I.Y. Tiong, G.L. Pearce, M.S. Lauer, D.L. Sprecher, and B.P. Griffin Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis Circulation 104 2001 2205 2209
7. W.S. Aronow, A. Chul, I. Kronzon, and M.E. Goldman Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older patients Am J Cardiol 88 2001 693 695
8. D.M. Shavelle, J. Takasu, M.J. Budoff, S. Mao, X.Q. Zhao, and K.D. O'Brien HMG CoA reductase inhibitor (statin) and aortic valve calcium Lancet 359 2002 1125 1126
9. R. Rosenhek, F. Rader, N. Loho, H. Gabriel, M. Heger, U. Klaar, M. Schemper, T. Binder, G. Maurer, and H. Baumgartner Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis Circulation 110 2004 1291 1295
10. L.M. Moura, S.F. Ramos, J.L. Zamorano, I.M. Barros, L.F. Azevedo, F. Rocha-Gonalves, and N.M. Rajamannan Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis J Am Coll Cardiol 49 2007 554 561
11. S.J. Cowell, D.E. Newby, R.J. Prescott, P. Bloomfield, J. Reid, D.B. Northridge, and N.A. Boon Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis N Engl J Med 352 2005 2389 2397
12. A.B. Rossebø, T.R. Pedersen, K. Boman, P. Brudi, J.B. Chambers, K. Egstrup, E. Gerdts, C. Gohlke-Brwolf, I. Holme, Y.A. Kesniemi, W. Malbecq, C.A. Nienaber, S. Ray, T. Skjaerpe, K. Wachtell, R. Willenheimer SEAS Investigators Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis N Engl J Med 359 2008 1343 1356
13. K.L. Chan, K. Teo, J.G. Dumesnil, A. Ni, J. Tam ASTRONOMER Investigators Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial Circulation 121 2010 306 314
14. F. Antonini-Canterin, M. Hru, B.A. Popescu, E. Leiballi, R. Piazza, D. Pavan, C. Ginghin, and G.L. Nicolosi Stage related effect of statin treatment on the progression of aortic valve sclerosis and stenosis Am J Cardiol 102 2008 738 742
15. F. Antonini-Canterin, E. Leiballi, R. Enache, B.A. Popescu, M. Roca, E. Cervesato, R. Piazza, C. Ginghin, and G.L. Nicolosi Hydroxymethylglutaryl coenzyme-a reductase inhibitors delay the progression of rheumatic aortic valve stenosis a long-term echocardiographic study J Am Coll Cardiol 53 2009 1874 1879
16. A.B. Rossebo, T.R. Pedersen, C. Allen, K. Boman, J. Chambers, K. Egstrup, E. Gerdts, C. Gohlke-Brwolf, I. Holme, V.A. Kesaniemi, W. Malbeq, C. Nienaber, S. Ray, T. Skjaerpe, K. Wachtell, and R. Willenheimer Design and baseline characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study Am J Cardiol 99 2007 970 973
17. D. Cramariuc, A.E. Rieck, E.M. Staal, K. Wachtell, E. Eriksen, A.B. Rossebø, and E. Gerdts Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis Am J Cardiol 101 2008 510 515
18. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, W.J. Stewart Chamber Quantification Writing Group American Society of Echocardiography's Guidelines and Standards Committee European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
19. R.O. Bonow, B.A. Carabello, C. Kanu, A.C. de Leon Jr, D.P. Faxon, M.D. Freed, W.H. Gaasch, B.W. Lytle, R.A. Nishimura, P.T. O'Gara, R.A. O'Rourke, C.M. Otto, P.M. Shah, J.S. Shanewise, S.C. Smith Jr, A.K. Jacobs, C.D. Adams, J.L. Anderson, E.M. Antman, D.P. Faxon, V. Fuster, J.L. Halperin, L.F. Hiratzka, S.A. Hunt, B.W. Lytle, R. Nishimura, R.L. Page, B. Riegel American College of Cardiology/American Heart Association Task Force on Practice Guidelines Society of Cardiovascular Anesthesiologists Society for Cardiovascular Angiography and Interventions Society of Thoracic Surgeons ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons Circulation 114 2006 e84 e231
20. C.M. Otto, B.K. Lind, D.W. Kitzman, B.J. Gersh, and D.S. Siscovick Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly N Engl J Med 341 1999 142 147
21. C.M. Otto, I.G. Burwash, M.E. Legget, B.I. Munt, M. Fujioka, N.L. Healy, C.D. Kraft, C.Y. Miyake-Hull, and R.G. Schwaegler Prospective study of asymptomatic valvular aortic stenosis Clinical, echocardiographic, and exercise predictors of outcome Circulation 95 1997 2262 2270
22. S. Palta, A.M. Pai, K.S. Gill, and R.G. Pai New insights into the progression of aortic stenosis: implications for secondary prevention Circulation 101 2000 2497 2502